SM-Youtube

Year	Number of Results
1965	7
1966	14
1967	16
1968	21
1969	12
1970	12
1971	11
1972	17
1973	11
1974	7
1975	13
1976	13
1977	14
1978	16
1979	15
1980	41
1981	28
1982	29
1983	31
1984	43
1985	54
1986	65
1987	43
1988	62
1989	91
1990	104
1991	75
1992	87
1993	83
1994	63
1995	76
1996	70
1997	92
1998	89
1999	90
2000	90
2001	90
2002	103
2003	126
2004	133
2005	141
2006	155
2007	159
2008	162
2009	163
2010	176
2011	180
2012	205
2013	234
2014	264
2015	268
2016	297
2017	263
2018	273
2019	351
2020	390
2021	433
2022	496
2023	463
2024	311

Year

Number of Results

1965

1966

1967

1968

1969

1970

1971

1972

1973

1974

1975

1976

1977

1978

1979

1980

1981

1982

1983

1984

1985

1986

1987

1988

1989

1990

104

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

103

2003

126

2004

133

2005

141

2006

155

2007

159

2008

162

2009

163

2010

176

2011

180

2012

205

2013

234

2014

264

2015

268

2016

297

2017

263

2018

273

2019

351

2020

390

2021

433

2022

496

2023

463

2024

311

Page 1

Anticoagulation Therapy in Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy.

Kido K, Guglin M. Kido K, et al. J Cardiovasc Pharmacol Ther. 2019 Jan;24(1):31-36. doi: 10.1177/1074248418783745. Epub 2018 Jun 18. J Cardiovasc Pharmacol Ther. 2019. PMID: 29911432

Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Sebastian SA, Padda I, Lehr EJ, Johal G. Sebastian SA, et al. Am J Cardiovasc Drugs. 2023 Sep;23(5):519-532. doi: 10.1007/s40256-023-00599-0. Epub 2023 Aug 1. Am J Cardiovasc Drugs. 2023. PMID: 37526885 Review.

Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathy.

Dewanjee S, Vallamkondu J, Kalra RS, John A, Reddy PH, Kandimalla R. Dewanjee S, et al. Ageing Res Rev. 2021 Jul;68:101338. doi: 10.1016/j.arr.2021.101338. Epub 2021 Apr 7. Ageing Res Rev. 2021. PMID: 33838320 Review.

Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy.

Du S, Shi H, Xiong L, Wang P, Shi Y. Du S, et al. Front Endocrinol (Lausanne). 2022 Oct 14;13:1011669. doi: 10.3389/fendo.2022.1011669. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36313744 Free PMC article.

Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.

Zhang Y, Sun C, Li Y, Qin J, Amancherla K, Jing Y, Hu Q, Liang K, Zhang Z, Ye Y, Huang LA, Nguyen TK, Egranov SD, Zhao Z, Wu A, Xi Y, Yao J, Hung MC, Calin GA, Cheng J, Lim B, Lehmann LH, Salem JE, Johnson DB, Curran MA, Yu D, Han L, Darabi R, Yang L, Moslehi JJ, Lin C. Zhang Y, et al. Sci Transl Med. 2022 Nov 2;14(669):eabo1981. doi: 10.1126/scitranslmed.abo1981. Epub 2022 Nov 2. Sci Transl Med. 2022. PMID: 36322628 Free PMC article.

Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy.

Xing Y, Sui Z, Liu Y, Wang MM, Wei X, Lu Q, Wang X, Liu N, Lu C, Chen R, Wu M, Wang Y, Zhao YH, Guo F, Cao JL, Qi J, Wang W. Xing Y, et al. Basic Res Cardiol. 2022 Apr 7;117(1):20. doi: 10.1007/s00395-022-00930-x. Basic Res Cardiol. 2022. PMID: 35389129

Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway.

Yang T, Liu H, Yang C, Mo H, Wang X, Song X, Jiang L, Deng P, Chen R, Wu P, Chen A, Yan J. Yang T, et al. Drug Des Devel Ther. 2023 Aug 22;17:2495-2511. doi: 10.2147/DDDT.S409232. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37637264 Free PMC article.

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.

Rapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, Boman K, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Rapezzi C, et al. JACC Heart Fail. 2021 Feb;9(2):115-123. doi: 10.1016/j.jchf.2020.09.011. Epub 2020 Dec 9. JACC Heart Fail. 2021. PMID: 33309574 Free article.

Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function.

Zhu XX, Wang X, Jiao SY, Liu Y, Shi L, Xu Q, Wang JJ, Chen YE, Zhang Q, Song YT, Wei M, Yu BQ, Fielitz J, Gonzalez FJ, Du J, Qu AJ. Zhu XX, et al. Acta Pharmacol Sin. 2023 Nov;44(11):2184-2200. doi: 10.1038/s41401-023-01107-5. Epub 2023 Jun 16. Acta Pharmacol Sin. 2023. PMID: 37328648

Ginsenoside Rb1 Inhibits Cardiomyocyte Autophagy via PI3K/Akt/mTOR Signaling Pathway and Reduces Myocardial Ischemia/Reperfusion Injury.

Qin GW, Lu P, Peng L, Jiang W. Qin GW, et al. Am J Chin Med. 2021;49(8):1913-1927. doi: 10.1142/S0192415X21500907. Epub 2021 Nov 13. Am J Chin Med. 2021. PMID: 34775933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

6,741 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Search Results

6,741 results

Results by year